Novel therapeutic agents provide hope for patients with hard-to-treat blood disorders

Ongoing discoveries of critical molecular markers, pathways, and other drivers of some of the most difficult-to-treat forms of blood cancer have provided unprecedented opportunities for the development of new targeted therapies that attack, block, and silence the deadly genetic mutations that cause these disorders.

http://www.sciencedaily.com/releases/2012/12/121209152636.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine%2Fcancer+%28ScienceDaily%3A+Health+%26+Medicine+News+--+Cancer%29